Live Breaking News & Updates on Medical expertise provide

Stay informed with the latest breaking news from Medical expertise provide on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medical expertise provide and stay connected to the pulse of your community

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 1,050,000 shares, a decrease of 15.3% from the March 31st total of 1,240,000 shares. Based on an average daily volume of 341,300 shares, […]

Chicago , Illinois , United-states , Acumen-pharmaceuticals , Jump-financial , Acumen-pharmaceuticals-company-profile , Acumen-pharmaceuticals-trading , News-ratings-for-acumen-pharmaceuticals-daily , Acumen-pharmaceuticals-inc , Franklin-resources-inc , Parkman-healthcare-partners

LivaNova (LIVN) Set to Announce Earnings on Wednesday

LivaNova (NASDAQ:LIVN – Get Free Report) is scheduled to release its earnings data before the market opens on Wednesday, May 1st. Analysts expect LivaNova to post earnings of $0.47 per share for the quarter. LivaNova has set its FY 2024 guidance at 2.950-3.050 EPS and its FY24 guidance at $2.95-3.05 EPS.Investors interested in registering for […]

Robertw-baird , Needham-company , Barclays , Livanova-company-profile , Get-free-report , Advanced-circulatory-support , Livanova-daily , Livanova , Nasdaq-livn , Livn , Medical

RedHill Biopharma (NASDAQ:RDHL) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. RedHill Biopharma Stock Performance Shares of RDHL opened at $0.43 on Friday. RedHill Biopharma has a 1 year low of $0.26 and a 1 year […]

Redhill-biopharma , Sabby-management , Redhill-biopharma-ltd , Securities-exchange-commission , Nasdaq , Free-report , Hill-biopharma , Get-free-report , Hill-biopharma-ltd , Redhill-biopharma-daily , Nasdaq-rdhl , Rdhl

Forza Wealth Management LLC Sells 260 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Forza Wealth Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 30.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 583 shares of the healthcare conglomerate’s stock after selling 260 shares during the […]

Canada , United-states , Thomase-roos , Erin-mcsweeney , Robbins-farley , News-ratings-for-unitedhealth-group-daily , Morgan-stanley , Exchange-commission , Securities-exchange-commission , Financial-services , Newsquare-capital , Cantor-fitzgerald

Bristol-Myers Squibb (NYSE:BMY) Price Target Lowered to $48.00 at BMO Capital Markets

Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price cut by BMO Capital Markets from $55.00 to $48.00 in a report issued on Friday morning, Benzinga reports. They currently have a market perform rating on the biopharmaceutical company’s stock. Other analysts have also recently issued research reports about the stock. Redburn Atlantic cut shares […]

United-states , Philadelphia , Pennsylvania , America , Bristol-myers-squibb , Pomalyst-imnovid , Redburn-atlantic , Societe-generale , William-blair , Pacer-advisors-inc , Bristol-myers-squibb-company , Primecap-management-co

StockNews.com Begins Coverage on VBI Vaccines (NASDAQ:VBIV)

StockNews.com initiated coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Performance Shares of NASDAQ VBIV opened at $0.56 on Friday. VBI Vaccines has a 52-week low of $0.45 and […]

Vaccines-company-profile , Vaccines-inc , Free-report , Get-free-report , Vbi-vaccines , Nasdaq-vbiv , Vbiv , Medical , Initiated-coverage , Stocknews-com ,

Acorda Therapeutics (NASDAQ:ACOR) Receives New Coverage from Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “buy” rating on the biopharmaceutical company’s stock. Acorda Therapeutics Stock Down 24.9 % ACOR stock opened at $0.66 on Friday. The firm has a 50-day moving […]

United-states , Acorda-therapeutics , Acorda-therapeutics-inc , Get-free-report , Therapeutics-stock-down , Acorda-therapeutics-daily , Nasdaq-acor , Acor , Medical , 00484m10 , Initiated-coverage

ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com

Equities researchers at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the stock. ObsEva Price Performance NASDAQ:OBSV opened at $0.01 on Friday. The business’s 50-day simple moving average is $0.02 and its 200-day simple moving average is […]

Geneva , Genè , Switzerland , Ernest-loumaye , Nasdaq , Obseva-company-profile , Get-free-report , Obseva-daily , Obseva , Nasdaq-obsv , Obsv , Medical

DBV Technologies (NASDAQ:DBVT) Now Covered by StockNews.com

StockNews.com started coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the stock. Separately, HC Wainwright reissued a “buy” rating and set a $10.00 target price on shares of DBV Technologies in a research report on Wednesday, February 21st. […]

Technologies-company-profile , Nasdaq , Optiver-holding , Get-free-report , Viaskin-peanut , Viaskin-milk , Dbv-technologies , Nasdaq-dbvt , Dbvt , Medical , Initiated-coverage

Cantor Fitzgerald Brokers Boost Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for shares of Merck & Co., Inc. in a research report issued on Friday, April 26th. Cantor Fitzgerald analyst L. Chen now forecasts that the company will post earnings of $8.53 per […]

Colorado , United-states , Wellington , New-zealand-general- , New-zealand , Gardasil , Joseph-romanelli , Steven-mizell , Barclays , Merck-co-inc , Animal-health , Insider-activity-at-merck-co-inc